Quest Diagnostics Continuing Medical Education

Welcome to the Quest Diagnostics Continuing Medical Education (CME) page. Below are links to CME learning opportunities that are available to you with the permission of the accredited providers. Activities were selected, whether in part or in whole, for their appropriateness to the practice of clinical medicine.

Prescription Drug Monitoring in Chronic Opioid Therapy: Employing Urine Drug Testing to Optimize Patient Outcomes in Chronic Opioid Use

Description: The routine use of Urine Drug Testing (UDT) according to current prescription drug monitoring guidelines allows for a comprehensive assessment of opioid misuse grounded in policy, rather than decisions based on individual patient characteristics, decreasing the stigma that can be associated with this type of testing. In this video vignette, 2 experts will discuss the benefit of standardized UDT and how to implement current prescription drug monitoring guidelines into clinical practice to ensure maximal therapeutic effect, while mitigating opioid misuse, abuse, accidental overdose, and death.

This link is presented with permission from Pri-Med

CME Expiration Date: 10/24/2019

Prescription Drug Monitoring in Chronic Opioid Therapy: Employing Urine Drug Testing to Optimize Patient Outcomes - How to perform Urine Drug Testing and Interpret Results

Description: Urine drug testing is an effective tool to assess for adherence to opioid therapy, misuse, and abuse. In this 15-minute activity, esteemed faculty discuss the differences between presumptive (screening) and definitive (confirmatory) urine drug testing, including their respective advantages and drawbacks and reasons why false-positive and false-negative results occur

This link is presented with permission from Pri-Med

CME Expiration Date: 08/28/2019

Prescription Drug Monitoring in Chronic Opioid Therapy: Employing Urine Drug Testing to Optimize Patient Outcomes

Description: Prescription drug monitoring is an effective tool to help mitigate risks associated with opioid therapy, such as misuse, abuse, overdose, and death. The most objective method of assessing medication adherence and misuse is urine drug testing (UDT). In this 15-minute video, 2 experts will discuss how to appropriately order UDT for patients receiving opioid therapy in order to 1) monitor and improve patient medication adherence, and 2) to assess for concomitant use of non-prescribed medications or drugs of abuse

This link is presented with permission from Pri-Med

CME Expiration Date: 06/22/2019

Autoantibody Testing for Connective Tissue Diseases: Primary Care Update

Description: This 30-minute Video Expert Dialogue discusses the role of autoantibody testing in evaluating autoimmune diseases or, more precisely, connective tissue diseases. Topics include how testing for autoantibodies, such as antinuclear antibodies (ANA), can be used in the primary care setting to diagnose autoimmune disorders. The emphasis is on the unique role primary care providers play in diagnosing and managing auitoimmune disorders and optimizing patient care.

This link is presented with permission from Medtelligence and PIM

CME Expiration Date: 03/26/2019

Expert Review of Case Studies for Autoantibody Testing for Autoimmune Diseases

Description: This innovative, 45-minute, case-based CME activity features two prominent faculty covering important, timely issues and data related to the detection of autoimmune (AI) disorders, including evaluation and utilization of current biomarkers for diagnosis of early RA (such as antinuclear antibody (ANA) presence, CCP antibody, 14-3-3η protein). Using case studies, the faculty will explore diagnosis and management strategies to maximize patient care.

This link is presented with permission from Medtelligence and PIM

CME Expiration Date: 04/27/2019

2018 National Lipid Association Spring Clinical Lipid Update Highlights

Description: This CME activity highlights presentations from selected sessions of the live NLA Spring Clinical Lipid Update conference. Experts discuss cardiovascular disease risk factor scoring and clinical assessment, genetic testing and its clinical utility in the diagnosis of familial hypercholesterolemia (FH), type 2 diabetes medications lending to cardiovascular risk reduction, and the role of human genetics in the efficacy of CETP inhibition.

This link is presented with permission from National Lipid Association (NLA)

CME Expiration Date: 04/19/2019

Evidence for the Increasing Role of Natriuretic Peptides in the Diagnosis and Management of Heart Failure.

Description: This webinar discusses evidence for the utility of natriuretic peptide testing to improve outcome, and presents case studies on the management of heart failure after admission and discharge.

This link is presented with permission from Medavera

CME Expiration Date: 11/29/2019

For comments or suggestions, please email CME@QuestDiagnostics.com

These CME activities are provided for informational purposes only and are not intended as medical advice. A physician’s test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education, clinical expertise, and assessment of the patient.